Plaque-Psoriasis
Adalimumab, Humira®; Biosimilars: Amgevita®, Amsparity®, Hefiya®, Hukyndra®, Hulio®, Hyrimoz®, Idacio®, Imraldi®, Libmyris®, Yuflyma®, TNF-α, Apremilast, Otezla®, PDE-4, Bimekizumab, Bimzelx®, IL-17A/IL-17F/IL-17AF, Brodalumab, Kyntheum®, IL-17RA, Certolizumab Pegol, Cimzia®, Deucravacitinib, Sotyktu®, TYK2, Etanercept, Enbrel®; Biosimilars: Benepali®, Erelzi®, Nepexto®, Guselkumab, Tremfya®, IL-23, Infliximab, Remicade®; Biosimilars: Flixabi®, Inflectra®, Remsima®, Zessly®, Ixekizumab, Taltz®, IL-17A, Risankizumab, Skyrizi®, Secukinumab, Cosentyx®, Tildrakizumab, Ilumetri®, Ustekinumab, Stelara®, IL-12/IL-23